Risk of Safety Events Among Patients with UC and PsA Treated with Tofacitinib and Other Advanced Treatments in the United States

First published 19/04/2023

Last updated 14/03/2025

EU PAS number:

EUPAS103443

Study

Ongoing

Documents

Study protocol

Initial protocol

A3921431 Non-Interventional Study Protocol v1.0 (PASS)_22 February 2023_Redacted

English (1005.83 KB - PDF)View document

Updated protocol

A3921431 Non-Interventional Study Protocol V3.0 18Nov2024.pdf

First published: 29/11/2024

English (243.52 KB - PDF)View document

Study results

Study report

Other information

Study, other information

A3921431 Non Interventional PASS ABSTRACT 22Feb2023_Redacted

English (323.73 KB - PDF)View document

A3921431 Non-Interventional Study Protocol V3.0 18Nov2024.pdf

English (243.52 KB - PDF)View document

ENCePP Seal

ENCePP Seal documents

Secondary tabs